DK1543063T3 - Medikament levering - Google Patents

Medikament levering

Info

Publication number
DK1543063T3
DK1543063T3 DK03748273T DK03748273T DK1543063T3 DK 1543063 T3 DK1543063 T3 DK 1543063T3 DK 03748273 T DK03748273 T DK 03748273T DK 03748273 T DK03748273 T DK 03748273T DK 1543063 T3 DK1543063 T3 DK 1543063T3
Authority
DK
Denmark
Prior art keywords
drug delivery
relates
delivery
drugs
solubilising
Prior art date
Application number
DK03748273T
Other languages
Danish (da)
English (en)
Inventor
Ijeoma Uchegbu
Andreas Schatzlein
Woei Ping Cheng
Original Assignee
Univ London Pharmacy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London Pharmacy filed Critical Univ London Pharmacy
Application granted granted Critical
Publication of DK1543063T3 publication Critical patent/DK1543063T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • C08G73/0213Preparatory process
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • C08G73/0213Preparatory process
    • C08G73/0226Quaternisation of polyalkylene(poly)amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03748273T 2002-09-20 2003-09-22 Medikament levering DK1543063T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0221942.6A GB0221942D0 (en) 2002-09-20 2002-09-20 Drug delivery
PCT/GB2003/004036 WO2004026941A1 (en) 2002-09-20 2003-09-22 Drug delivery

Publications (1)

Publication Number Publication Date
DK1543063T3 true DK1543063T3 (da) 2009-05-18

Family

ID=9944516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03748273T DK1543063T3 (da) 2002-09-20 2003-09-22 Medikament levering

Country Status (11)

Country Link
US (1) US20060148982A1 (enExample)
EP (1) EP1543063B1 (enExample)
JP (1) JP2006500437A (enExample)
AT (1) ATE426635T1 (enExample)
AU (1) AU2003267581A1 (enExample)
CA (1) CA2499681A1 (enExample)
DE (1) DE60326859D1 (enExample)
DK (1) DK1543063T3 (enExample)
GB (1) GB0221942D0 (enExample)
SI (1) SI1543063T1 (enExample)
WO (1) WO2004026941A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422877D0 (en) * 2004-10-14 2004-11-17 Univ Glasgow Bioactive polymers
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
WO2007084126A1 (en) 2006-01-19 2007-07-26 Allexcel, Inc. Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
BRPI0707305A2 (pt) * 2006-01-27 2011-05-03 Ciba Holding Inc agentes antimicrobianos poliméricos
EP2500015A1 (en) * 2006-12-05 2012-09-19 Landec Corporation Delivery of drugs
US20090263346A1 (en) * 2006-12-05 2009-10-22 David Taft Systems and methods for delivery of drugs
US20090246155A1 (en) * 2006-12-05 2009-10-01 Landec Corporation Compositions and methods for personal care
US20100004124A1 (en) * 2006-12-05 2010-01-07 David Taft Systems and methods for delivery of materials for agriculture and aquaculture
US8399007B2 (en) * 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
CN101568630B (zh) * 2006-12-22 2012-02-08 巴斯夫欧洲公司 用作染料转移抑制剂的疏水改性聚亚烷基亚胺
AP2941A (en) * 2007-07-19 2014-07-31 Allexcel Inc Self-assembling amphiphilic polymers as anticanceragents
US8114883B2 (en) * 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
GB0903559D0 (en) 2009-03-02 2009-04-08 Univ London Pharmacy Oral delivery of hydrophilic drugs to the brain
MX342897B (es) 2009-04-28 2016-10-18 Surmodics Inc Dispositivos y metodos para suministrar agentes bioactivos.
GB0915449D0 (en) 2009-09-04 2009-10-07 Univ Robert Gordon Composition
CA2797709C (en) 2010-04-28 2018-07-31 Jason J. Locklin Photochemical cross-linkable polymers, methods of making photochemical cross-linkable polymers, methods of using photochemical cross-linkable polymers, and methods of making articles containing photochemical cross-linkable polymers
US8721936B2 (en) 2011-04-21 2014-05-13 University Of Georgia Research Foundation, Inc. Devices and methods for forming non-spherical particles
US9861727B2 (en) 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
WO2013012664A2 (en) 2011-07-15 2013-01-24 The University Of Georgia Research Foundation, Inc Permanent attachment of agents to surfaces containing c-h functionality
WO2013019918A2 (en) 2011-08-04 2013-02-07 The University Of Georgia Research Foundation, Inc. Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing-oh functionality
US9839213B2 (en) 2011-10-14 2017-12-12 The University Of Georgia Research Foundation, Inc. Photochemical cross-linkable polymers, methods of making photochemical cross-linkable polymers, methods of using photochemical cross-linkable polymers, and methods of making articles containing photochemical cross-linkable polymers
WO2014071387A1 (en) 2012-11-05 2014-05-08 Surmodics, Inc. Composition and method for delivery of hydrophobic active agents
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
US12226552B2 (en) 2019-09-30 2025-02-18 Surmodics, Inc. Active agent depots formed in situ

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US5681543A (en) * 1988-02-29 1997-10-28 Shering Aktiengesellschaft Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
JPH01236240A (ja) * 1989-01-14 1989-09-21 Miyoshi Oil & Fat Co Ltd 新規な高分子化合物
DE3901527A1 (de) * 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
JP3406970B2 (ja) * 1993-12-27 2003-05-19 ミヨシ油脂株式会社 両性界面活性剤
JP3526661B2 (ja) * 1995-06-23 2004-05-17 ミヨシ油脂株式会社 抗菌剤、抗菌性樹脂及び抗菌性塗料
EP0912493A1 (en) * 1996-06-19 1999-05-06 The Procter & Gamble Company Process for removing malodors from modified polyamines
WO1999043752A1 (fr) * 1998-02-27 1999-09-02 Dnavec Research Inc. Compositions pour transporter des substances chargees negativement
JP3523821B2 (ja) * 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
JP2004510829A (ja) * 2000-10-09 2004-04-08 バイエル アクチェンゲゼルシャフト 核酸を細胞内に転移させるための複合体
DE10065710A1 (de) * 2000-12-29 2002-07-04 Bayer Ag Arzneimittel enthaltend ein Polyamin als Wirksubstanz
GB0221941D0 (en) * 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps

Also Published As

Publication number Publication date
EP1543063A1 (en) 2005-06-22
AU2003267581A1 (en) 2004-04-08
DE60326859D1 (de) 2009-05-07
GB0221942D0 (en) 2002-10-30
CA2499681A1 (en) 2004-04-01
AU2003267581A8 (en) 2004-04-08
SI1543063T1 (sl) 2009-08-31
WO2004026941A1 (en) 2004-04-01
US20060148982A1 (en) 2006-07-06
ATE426635T1 (de) 2009-04-15
JP2006500437A (ja) 2006-01-05
EP1543063B1 (en) 2009-03-25

Similar Documents

Publication Publication Date Title
DK1543063T3 (da) Medikament levering
EP2004172A4 (en) ACTIVE INK PROCESSING, STRUCTURES AND COMPOSITIONS FOR NASOLACRIMAL SYSTEM
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
BRPI0514293A (pt) sais de dicetopiperazina, sais de dicetomorfolina ou sais de dicetodioxano para administração de droga
CY1112946T1 (el) 4-υδροξυβενζομορφανια
CY1118179T1 (el) Φαρμακευτικη συνθεση
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
CY1111458T1 (el) Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
EA200301250A1 (ru) Фармацевтические композиции, содержащие слаборастворимые и/или чувствительные к кислотам лекарственные средства и нейтрализованные кислотные полимеры
EA200600877A1 (ru) Наночастицы для доставки лекарств
HUE040046T2 (hu) Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
DE60327693D1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
PL1909843T3 (pl) Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne i ich zastosowanie w dziedzinie farmacji
CY1108854T1 (el) Οροδιασπειρoμενη φαρμακευτικη συνθεση ιβαβραδινης
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
ATE411981T1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
DK1781277T3 (da) Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol
EP1503748A4 (en) DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY
ATE434431T1 (de) Pharmazeutische formulierungen mit kurzketten- sphingolipiden und ihre verwendung
DK1682144T3 (da) Smagsstofholdige lægemiddelformuleringer med forbedrede farmaceutiske egenskaber
EA200501301A1 (ru) Ментоловые растворы лекарственных препаратов
NO20076120L (no) Stabile nanopartikkelformuleringer